Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours ; volume:21 ; number:1 ; day:19 ; month:1 ; year:2021 ; pages:103-111 ; date:3.2021
Drugs in R & D ; 21, Heft 1 (19.1.2021), 103-111, 3.2021
- Creator
-
Vermunt, Marit A. C.
Weger, Vincent A. de
Janssen, Julie M.
Lopez-Yurda, Marta I.
Keessen, Marianne
Thijssen, Bas
Rosing, Hilde
Huitema, Alwin D. R.
Beijnen, Jos H.
Marchetti, Serena
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-020-00336-x
- URN
-
urn:nbn:de:101:1-2021042718584883138985
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vermunt, Marit A. C.
- Weger, Vincent A. de
- Janssen, Julie M.
- Lopez-Yurda, Marta I.
- Keessen, Marianne
- Thijssen, Bas
- Rosing, Hilde
- Huitema, Alwin D. R.
- Beijnen, Jos H.
- Marchetti, Serena
- SpringerLink (Online service)
Other Objects (12)
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules
Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance
Tutoring with Stylus-enabled Tablets
Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19
Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
Perioperative management of patients with pituitary tumours
Targeting Bone Tumours with 45S5 Bioactive Glass
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules
Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance
Tutoring with Stylus-enabled Tablets
Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19
Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
Perioperative management of patients with pituitary tumours
Targeting Bone Tumours with 45S5 Bioactive Glass
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules
Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance
Tutoring with Stylus-enabled Tablets
Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19
Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
Perioperative management of patients with pituitary tumours